ArticleAnnals of translational medicine2019

A randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients.

Tao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.